From Tuesday, 9 to 14 July at the “Stazione Marittima” Conference Centre in Trieste, Lawrence Banks, ICGEB Director-General hosts the 50th Anniversary edition of the DNA Tumour Virus Meeting
The 50th edition of the International Meeting on Tumour Viruses, one of the most important international meetings in the field has taken place in Trieste, with over 300 participants from over 35 different countries: predominantly from the USA, but also from Europe, Latin America, Asia, Africa, and Australia.
Amongst the Keynote speakers, John Schiller, inventor of the HPV vaccine, who will speak on the future challenges in cancer therapy. The Conference is also the first official engagement of the new ICGEB Director-General, Lawrence Banks.
The Congress is the sixth in the Conference series organised in memory of Arturo Falaschi, the mind and driving force in the establishment of the ICGEB, Director-General from 1989-2004.
Focusing on viruses that cause tumours, the Meeting has been held each year since 1969, first alternating between Cold Spring Harbour, USA and Cambridge, UK, and, more recently, in Madison and San Diego, USA, Montreal, Canada, Oxford and Birmingham, UK and in Trieste, Italy (in 2015, 2011, 2007, and 2003).
More than 10% of tumours that affect humans are the consequence of viral infection. These tumours include cervical cancer, different types of leukemia, liver and skin cancer. The Congress, which starts at 5 pm, will host several key experts in the field to discuss the most innovative discoveries, strategies, and cures available today.
On Thursday, 12 July, John Schiller, NIH, Maryland, Bethesda, USA, world leader in DNA Tumour Virus research and co-inventor of the HPV vaccine, discusses the challenges for the way in which the field can continue to improve cancer therapy. Silvio Perea, CIGB, Havana, Cuba, historic Affiliated Centre of the ICGEB, presents a novel therapeutic against HPV induced cancer in clinical trials in Cuba. John Doorbar, Department of Pathology, University of Cambridge, present sdisinfection and prevention strategies in clinical settings. Five days, over 100 presentations and poster sessions.
James M. Pipas, University of Pittsburgh is the keynote speaker in the session sponsored by AIRC and focuses on what the study of these viruses has given back to cancer research.
A truly rich and high-level gathering by scientists, bringing Trieste once again to the forefront in world scientific research.